CETP and age-related macular degeneration: Emerging research also underscores the potential of CETP inhibitors in treating various conditions where inflammation is critical, including neurodegenerative diseases such as Alzheimer’s disease, age-related macular degeneration (AMD), and severe inflammatory states such as sepsis [254].